ACR & EULAR recommendations for the treatment of patients with rheumatic illness during the COVID-19 pandemic are explored…
Search results for: Social media
Advocacy in a COVID-19 America
These are truly extraordinary times. The COVID-19 pandemic has affected the rheumatology community, both providers and patients, in many ways, and our advocacy efforts are now more important than ever to ensure policymakers hear us and help address the issues facing our community. As with so many things during this pandemic, we are reimagining advocacy…
The COVID-19 Infection Inflammation Equation
The uncertainty is certain Let us draw up the curtain Unmask this serial killer’s intention. Attack of its clones gone viral Made distancing societal Disrupting every human convention. Humble hydroxychloroquine Now forced into the scene Telehealth bridges our care. Drive-thru testing PPE and sanitizing Social media fills the air. But let’s not be deceived This…
Capitol Hill Rheumatology Advocacy Goes Virtual
ACR volunteer leaders and staff will convene more than 100 meetings via teleconference with Congressional leaders on May 22, addressing rheumatology provider solvency and patient access to care amidst the COVID-19 pandemic.
The COVID-19 Global Rheumatology Alliance: Its Genesis, Development & Goals
Editor’s note: We are sad to announce that we have learned of the passing of Dr. Philip C. Robinson. We will share more as it becomes available, but in the meantime, we wanted to repost this article he wrote for The Rheumatologist early in the pandemic. Dr. Robinson also took the photo of the full-arc rainbow below.
The COVID-19 Pandemic: What You Should Know
Two rheumatologists offer advice on patient management during the COVID-19 pandemic.
Old Drug, New Interest: COVID-19 Spurs Hydroxychloroquine Supply Concerns for Rheumatic Disease Patients
After a study investigated if hydroxycholoroquine (HCQ) benefits COVID-19 patients, the drug—used to treat SLE and RA patients—began running out in pharmacies around the U.S. ACR leaders have asked the FDA to increase monitoring of the HCQ supply…
New Membership & Nominations Chair Dr. Hazel Breland Outlines Goals for ARP Membership Growth
Having completed her term as ARP president, Hazel L. Breland, PhD, OTR/L, FAOTA, CLA, has stepped into a new role as chair of the ARP’s Membership and Nominations Committee (https://www.rheumatology.org/Rheumatology-Professionals). Dr. Breland is associate professor of occupational therapy at the Medical University of South Carolina (MUSC), Charleston, where she teaches graduate students and serves as…
New ACR/ARP Committee Members Are Ready to Work
Volunteering is a great way to give back and can be truly meaningful. Myriad worthwhile causes exist, so it can be hard to choose among them, but donating time to ACR and ARP committees helps promote rheumatology practice and brings awareness to rheumatic diseases. The College relies on volunteers to help achieve strategic priorities, promote…
ACR Advocacy: 2019 Year in Review
As a new year begins, Government Affairs Committee chair Blair Solow, MD, takes stock of ACR advocacy wins in 2019 and issues to watch in 2020.
- « Previous Page
- 1
- …
- 10
- 11
- 12
- 13
- 14
- …
- 49
- Next Page »